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Abstract
Introduction Fatty acids have been implicated in osteoarthritis
(OA), yet the mechanism by which fatty acids affect knee
structure and consequently the risk of knee OA has not been
fully elucidated. Higher intakes of fatty acids have been shown
to be associated with the risk of bone marrow lesions (BMLs) in
a healthy population. The aim of this study was to examine the
association between fatty acid consumption and the incidence
of BMLs in healthy middle-aged adults without clinical knee OA.
Methods Two hundred ninety-seven middle-aged adults without
clinical knee OA underwent magnetic resonance imaging (MRI)
of their dominant knee at baseline. BMLs were assessed. Of the
251 participants with no BMLs in their knee at baseline, 230
underwent MRI of the same knee approximately 2 years later.
Intakes of fatty acids were estimated from a food frequency
questionnaire.
Results Increased consumption of saturated fatty acids was
associated with an increased incidence of BMLs over 2 years
after adjusting for energy intake, age, gender, and body mass
index (odds ratio of 2.56 for each standard deviation increase in
dietary intake, 95% confidence interval 1.03 to 6.37, P = 0.04).
Intake of monounsaturated or polyunsaturated fatty acids was
not significantly associated with the incidence of BMLs.
Conclusions Increased fatty acid consumption may increase
the risk of developing BMLs. As subchondral bone is important
in maintaining joint integrity and the development of OA, this
study suggests that dietary modification of fatty acid intake may
be one strategy in the prevention of knee OA which warrants
further investigation.
Introduction
Nutritional factors have been shown to be important in the
maintenance of bone and joint health [1]. In particular, fatty
acids have been implicated in osteoarthritis (OA) [2,3]. Ele-
vated levels of fat and n-6 polyunsaturated fatty acids have
been found in OA bone [2], whereas n-3 polyunsaturated fatty
acids have been shown to alleviate progression of OA through
an effect on the metabolism of articular cartilage [3]. Although
dietary supplementation with polyunsaturated fatty acids has
been shown to decrease bone turnover and increase bone
mineral density [4], the finding that a higher ratio of n-6 to n-3
polyunsaturated fatty acids is associated with lower bone min-
eral density at the hip [5] suggests the important role of rela-
BMI: body mass index; BML: bone marrow lesion; CI: confidence interval; MCCS: Melbourne Collaborative Cohort Study; MRI: magnetic resonance 
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tive amounts of these polyunsaturated fatty acids in preserving
skeletal integrity in older age.
However, the mechanism by which polyunsaturated fatty acids
affect the knee structure and consequently the risk of knee OA
has not been fully elucidated. We have recently shown that
higher intakes of monounsaturated, total, and n-6 polyunsatu-
rated fatty acids were associated with an increased preva-
lence of bone marrow lesions (BMLs) in a healthy population
without clinical knee OA [6]. BMLs have been associated with
structural changes of disease severity, including increased
cartilage defects, tibial plateau area, loss of cartilage, and joint
space narrowing, suggesting that they play a role in the patho-
genesis of OA [7-9]. However, there are no longitudinal stud-
ies examining the role of fatty acids on incident BMLs in either
healthy or OA populations. Therefore, the aim of this study was
to examine the association between intakes of different types
of fatty acids and the incidence of BMLs in healthy, commu-
nity-based, middle-aged men and women with no clinical knee
OA.
Materials and methods
Subjects
This study was conducted within the Melbourne Collaborative
Cohort Study (MCCS), a prospective cohort study of 41,528
Melbourne, Australia residents who were 40 to 69 years old at
recruitment (1990 to 1994) [10]. Participants for the current
study were recruited from within the MCCS between 2003
and 2004 as previously described [6]. Briefly, participants
were eligible if they were between 50 and 79 years old without
any of the following exclusion criteria: a clinical diagnosis of
knee OA as defined by American College of Rheumatology cri-
teria [11], knee pain lasting for more than 24 hours in the last
5 years, a previous knee injury requiring non-weight-bearing
treatment for more than 24 hours or surgery (including arthros-
copy), or a history of any form of arthritis diagnosed by a med-
ical practitioner. A further exclusion criterion was a
contraindication to magnetic resonance imaging (MRI), includ-
ing pacemaker, metal sutures, presence of shrapnel or iron fil-
ings in the eye, or claustrophobia. The study was approved by
The Cancer Council Victoria's Human Research Ethics Com-
mittee and the Standing Committee on Ethics in Research
Involving Humans of Monash University. All participants gave
written informed consent.
Anthropometric and dietary data
Height was measured using a stadiometer with shoes
removed. Weight was measured using electronic scales with
bulky clothing removed. Body mass index (BMI) (weight/
height2, kg/m2) was calculated. At MCCS baseline, question-
naires covered demographic data and diet (via a 121-item
food frequency questionnaire developed from a study of
weighed food records [12]). Fatty acid intakes were calcu-
lated from the food frequency questionnaire using Australian
food composition data and were adjusted for energy intake
[13].
Magnetic resonance imaging and the measurement of 
bone marrow lesions
Each subject had an MRI performed on the dominant knee,
determined from kicking preference [14], at baseline and
approximately 2 years later. Knees were imaged on a 1.5-T
whole-body magnetic resonance unit (Philips Medical Sys-
tems, Eindhoven, The Netherlands) using a commercial trans-
mit-receive extremity coil, with coronal T2-weighted fat-
saturated acquisition as previously described [9]. BMLs were
defined as areas of increased signal intensity adjacent to sub-
cortical bone present in either the medial or lateral, distal femur
or proximal tibia [9]. Two trained observers, blinded to patient
characteristics and sequence of images, together assessed
the presence of lesions for each subject. The baseline and fol-
low-up images were assessed unpaired. A lesion was defined
as present if it appeared on two or more adjacent slices and
encompassed at least one quarter of the width of the tibial or
femoral cartilage being examined from coronal images, equiv-
alent to a 'large BML' as described by Felson and colleagues
[9]. The reproducibility for determination of BMLs was
assessed using 60 randomly selected knee MRIs (κ value
0.88, P < 0.001).
Statistical analyses
The descriptive statistics of the characteristics of study partic-
ipants were tabulated. Participants with self-reported total
energy intakes in the top or bottom 1% of the gender-specific
distributions were excluded. A BML was defined as incident if
it was present at follow-up in the knees without BMLs at base-
line. Logistic regression models were constructed to explore
the relationship between fatty acid intakes and incident BMLs
after adjusting for potential confounders of age, gender, BMI,
and energy intake. Intake of fatty acids was standardised so
that the coefficients represent the effect of an increment of
one standard deviation (SD) in intake. P values of less than
0.05 were considered to be statistically significant. All analy-
ses were performed using the SPSS statistical package
(standard version 15.0.0; SPSS Inc., Cary, NC, USA).
Results
Two hundred ninety-seven subjects entered the study, and
four subjects were excluded due to having energy intakes in
the top or bottom 1% of the gender-specific distributions. Of
the 251 participants who did not have a BML at baseline, 230
(92%) completed the 2-year follow-up. Participants lost to fol-
low-up had a higher BMI (P = 0.04) compared with those who
completed follow-up. There were no significant differences in
consumption of saturated (P = 0.56), monounsaturated (P =
0.59), or polyunsaturated (P = 0.75) fatty acids between the
two groups. Thirty-two subjects developed BMLs at follow-up.
Participants who developed BMLs had a higher BMI (mean
[SD] 27.9 [5.3] versus 25.4 [3.8] kg/m2, P = 0.02) and higherAvailable online http://arthritis-research.com/content/11/3/R63
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energy intake-adjusted saturated fatty acid consumption
(mean [standard error] 35.7 [1.2] versus 33.0 [0.5] g/day, P =
0.03) when compared with those who did not. There was no
significant difference in terms of the energy intake-adjusted
consumption of monounsaturated and polyunsaturated fatty
acids (Table 1).
Although there was no significant association between fatty
acid consumption and the incidence of BMLs over 2 years in
univariate analysis, higher consumption of saturated fatty acids
was significantly associated with an increased risk of develop-
ing BMLs after adjusting for energy intake (Table 2, model 1).
For each SD increase in dietary intake of saturated fatty acids,
the risk of developing BMLs over 2 years increased 2.62-fold
(95% confidence interval [CI] 1.11 to 6.17). This relationship
persisted after further adjusting for age, gender, and BMI
(odds ratio 2.56, 95% CI 1.03 to 6.37) (Table 2, model 2). No
significant association between consumption of monounsatu-
rated or polyunsaturated fatty acids or n-6/n-3 ratio and inci-
dent BMLs was found in multivariate analyses (Table 2).
From MCCS baseline when dietary fatty acid intake data were
collected during 1990 to 1994 to the inception of current
study when baseline MRI was performed in 2003 to 2004, the
weight of participants increased by a mean of 2.1 kg (SD 5.2
kg). After adding weight gain to model 2, consumption of sat-
urated fatty acids persisted to be positively associated with
incident BMLs (odds ratio 2.54, 95% CI 1.01 to 6.39).
There was no evidence that BMI modified the association
between energy intake-adjusted dietary saturated fatty acid
consumption and incident BMLs when an interaction term for
BMI category × saturated fatty acid intake was included in the
logistic model with adjustment for energy intake. The P value
was 0.64 when BMI was categorised as less than 25 kg/m2,
25 to 30 kg/m2, and greater than or equal to 30 kg/m2.
Discussion
In a population of healthy middle-aged adults with no clinical
knee OA, we found that higher intake of saturated, but not
monounsaturated or polyunsaturated, fatty acids or that the n-
6/n-3 ratio was associated with an increased likelihood of
developing BMLs over 2 years. This is the first longitudinal
study presenting a relationship between dietary fatty acid
intake and the incidence of BMLs. We have previously shown
in a cross-sectional study that increased dietary intake of
monounsaturated and n-6, but not n-3, polyunsaturated fatty
acids were associated with an increased risk of having BMLs
in a healthy population without clinical knee OA [6]. When this
population was followed up for 2 years, we found an associa-
tion between higher saturated fatty acid intake and increased
likelihood of developing BMLs over 2 years. Although the
mechanism for the discrepancy in terms of the type of fatty
acid consumption observed between the previous cross-sec-
tional study and the current prospective cohort study is
unclear, the adverse effect of saturated fatty acids on the inci-
dence of BMLs may be attributed to a vascular effect. Satu-
rated fatty acid intake has been associated with
atherosclerosis and cardiovascular disease [15]. There are no
previous studies identifying a relationship between saturated
fatty acid intake and the risk of OA. Recently, it has been sug-
gested that atheromatous vascular disease may be important
in the progression of OA [16] and that subchondral ischaemia
may be a mechanism by which vascular pathology plays a role
in the initiation and/or progression of OA [17]. The findings of
this study therefore suggest that vascular disease in subchon-
dral bone may play a role in the pathogenesis of OA via BMLs.
Table 1
Characteristics of study participants with no bone marrow lesions at baseline
Incident BMLs
(n = 32)
Without incident BMLs
(n = 198)
P valuea
Age, years 57.6 (5.8) 57.7 (5.0) 0.91
Number of females (percentage of females) 23 (72%) 120 (61%) 0.22b
Body mass index, kg/m2 27.9 (5.3) 25.4 (3.8) 0.02
Energy intake, kJ/d 8,822 (3,019) 9,293 (3,063) 0.42
Saturated fatty acid, g/day 35.7 (1.2) 33.0 (0.5) 0.03c
Monounsaturated fatty acids, g/day 29.3 (0.9) 27.9 (0.4) 0.14c
Polyunsaturated fatty acids, g/day 12.7 (0.7) 12.5 (0.3) 0.76c
n-3 polyunsaturated fatty acids, g/day 1.2 (0.05) 1.2 (0.02) 0.60c
n-6 polyunsaturated fatty acids, g/day 11.3 (0.6) 11.4 (0.3) 0.92c
n-6/n-3 ratio 9.6 (0.5) 9.7 (0.2) 0.82c
Data are presented as mean (standard deviation) unless otherwise stated. aP value for comparisons between two groups using independent 
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There is mounting evidence that BMLs play a role in the patho-
genesis of OA [7-9]. It has been demonstrated that BMLs are
associated with the presence of cartilage defects in healthy
asymptomatic populations with no history of significant knee
pain or injury and that risk factors for OA such as age, height,
and BMI also affect the prevalence of BMLs [18,19]. Moreo-
ver, the presence of BMLs predicts the progression of carti-
lage defects and loss of cartilage volume over 2 years in
longitudinal studies [20,21]. These findings suggest that
BMLs may be associated with an increased risk of knee OA.
This study demonstrates an increased incidence of BMLs
associated with increased saturated fatty acid intake in a
healthy population and suggests that modifying diet may be
one such way to reduce the development and subsequent bur-
den of OA.
This study has a number of potential limitations. First, this
study examined a healthy, community-based population
selected on the criterion of having no knee pain or injury and
therefore the results may not be generalisable to symptomatic
populations or people who have injured their knees. However,
the findings of our study can be generalised to populations
that would be targeted by primary prevention strategies. Sec-
ond, whilst the dietary intake of fatty acids was measured in a
valid fashion [22], this was based on a single measure of nutri-
ent intakes 10 years earlier. Although significant underreport-
ing of fat intake is likely [23], absolute intake of dietary fat
tends to remain stable [24,25]. While nutritional data collected
10 years earlier may have resulted in some misclassification of
exposure, such misclassification is likely to have been non-dif-
ferential in relation to knee structure since only subjects with
no history of knee symptoms or injury were included, thereby
tending to underestimate the strength of any observed associ-
ations. In the current study, we did not measure knee align-
ment, which has been shown to be associated with BMLs [9].
Conclusions
The findings of this study suggest that increased fatty acid
consumption may increase the risk of developing BMLs in a
healthy population without clinical knee OA. As subchondral
bone is important in maintaining joint integrity and the develop-
ment of OA, this study suggests that dietary modification of
fatty acid intake may be one strategy in the prevention of knee
OA which warrants further investigation.
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